If you already know your KOLs, at some point you will most likely want to perform a validation exercise to avoid the dangers of becoming over-familiar or over-confident in your list of Experts.
As the ASCO congress drew to a close, Johnson & Johnson filed for FDA approval of its BCMA-targeting CAR-T therapy Carvykti for use earlier in the treatment pathway fo
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas